Wednesday, July 16, 2014 12:31:25 AM
re;
It's just nice to see the word Cannabinoid coming from a real biopharmaceutical company trading on the nasdaq and not some fly by night OTC stock that suddenly pulls the word out of thin air because their business as an auto repair shop wasn't working out. ;)
I am skeptical that it would be, or become, anything like Sativex
but I am very curious to learn where this patent will take them, what it will bring into the pipeline, and what APD371 is really about.
Quote:
--------------------------------------------------------------------------------
APD371, an orally available agonist of the CB2 receptor, is an internally discovered investigational drug candidate Arena is exploring for several potential indications, including chronic pain.
This compound is designed to be highly selective to provide pain relief without psychotropic effects and without the potential for dependence or abuse.
Preclinical efficacy with APD371 has been shown in animal models of pain.
--------------------------------------------------------------------------------
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM